NCT05546736

Brief Summary

The aim of this study is to evaluate the effectiveness of the iCanWork intervention in assisting cancer survivors (CS) to return to work (RTW) and its impact on their health-related quality of life (QoL), health service utilization, RTW readiness, time to RTW, and work capacity.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
270

participants targeted

Target at P75+ for not_applicable

Timeline
4mo left

Started Apr 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Apr 2023Sep 2026

First Submitted

Initial submission to the registry

September 15, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 21, 2022

Completed
6 months until next milestone

Study Start

First participant enrolled

April 1, 2023

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Expected
Last Updated

September 26, 2022

Status Verified

September 1, 2022

Enrollment Period

2.4 years

First QC Date

September 15, 2022

Last Update Submit

September 22, 2022

Conditions

Keywords

return to workcancer survivorsvocational rehabilitationrandomized controlled trial

Outcome Measures

Primary Outcomes (1)

  • Change from baseline return to work status in the course of the 24-month study

    binary variable (Yes/No)

    baseline, 6 months, 12 months, 18 months, 24 months

Secondary Outcomes (3)

  • Change from baseline health related quality of life in the course of the 24-month study

    baseline, 6 months, 12 months, 18 months, 24 months

  • Change from baseline readiness to return to work in the course of the 24-month study

    baseline, 6 months, 12 months, 18 months, 24 months

  • Change from baseline work capacity in the course of the 24-month study

    baseline, 6 months, 12 months, 18 months, 24 months

Study Arms (2)

iCanWork Intervention

EXPERIMENTAL

iCanWork includes 6 1-hour sessions with a VRC and 1 to 4 1-hour sessions with an OT. In the positive event that a participant has returned to work during the study, three of the six VRC sessions are reserved to support the participants in their transition to the workplace.

Behavioral: iCanWork Intervention

Control

NO INTERVENTION

Participants randomized to the control group will receive their usual care and will be referred to the Cancer Work website for educational resources related to RTW. If they contact the team with RTW-related questions, they will be referred to their care teams.

Interventions

Participants will receive RTW support from the VRC and OT.

iCanWork Intervention

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosed with cancer (all types) treated with curative intent and of working age (between 18 and 65 at the time of diagnosis)
  • gainfully employed at the time of diagnosis (full or part-time, including students)
  • still on sick leave, including long-term disability leave, but for less than 2 years
  • has not started to return to work, since stopping due to cancer
  • can read and understand English or French
  • reside in Canada.

You may not qualify if:

  • \- If the cancer survivor's physicians consider returning to work unwise, such as due to a metastatic cancer diagnosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

McGill University

Montreal, Quebec, H3A 0G4, Canada

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 15, 2022

First Posted

September 21, 2022

Study Start

April 1, 2023

Primary Completion

September 1, 2025

Study Completion (Estimated)

September 1, 2026

Last Updated

September 26, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will share

Study Protocol will be published with an open access peer-reviewed journal

Shared Documents
STUDY PROTOCOL

Locations